Pharmaceutical Product Recalls: Category Effects and Competitor Response

References

• Appleby J, Krantz M (2004) Merck estimates $2.5B impact from pulling Vioxx plug. USA Today (September 30), http://usatoday30.usatoday.com/money/industries/health/drugs/2004-09-30-merck-cover_x.htm.Google Scholar
• Bala R, Bhardwaj P (2010) Detailing vs. direct-to-consumer advertising in the prescription pharmaceutical industry. Management Sci. 56(1):148–160.Link, Google Scholar
• Bala R, Bhardwaj P, Chen Y (2013) Offering pharmaceutical samples: The role of physician learning and patient payment ability. Marketing Sci. 32(3):522–527.Link, Google Scholar
• Bordalo P, Gennaioli N, Shleifer A (2016) Competition for attention. Rev. Econom. Stud. 83:481–513.Crossref, Google Scholar
• Cawley J, Rizzo J (2008) The spillover effects of prescription drug withdrawals. Adv. Health Econom. Health Services Res. 19:119–144.Crossref, Google Scholar
• Chen Y, Ganesan S, Liu Y (2009a) Does a firm’s product-recall strategy affect its financial value? An examination of strategic alternatives during product-harm crises. J. Marketing 73(6):214–226.Crossref, Google Scholar
• Chen Y, Joshi Y, Raju J, Zhang J (2009b) A theory of combative advertising. Marketing Sci. 28(1):1–19.Link, Google Scholar
• Cleeren K, van Heerde H, Dekimpe M (2013) Rising from the ashes: How brands and categories can overcome product-harm crises. J. Marketing 77(2):58–77.Crossref, Google Scholar
• Collins M, Simon K, Tennyson S (2013) Drug withdrawals and the utilization of therapeutic substitutes: The case of Vioxx. J. Econom. Behav. Organ. 86:148–168.Crossref, Google Scholar
• Davidson W, Worrell D (1992) Research notes and communications: The effect of product recall announcements on shareholder wealth. Strategic Management J. 13(6):467–473.Crossref, Google Scholar
• Dong X, Chintagunta P, Manchanda P (2011) A new multivariate count data model to study multi-category physician prescription behavior. Quant. Marketing Econom. 9(3):301–337.Crossref, Google Scholar
• Freedman S, Kearney M, Lederman M (2012) Product recalls, imperfect information, and spillover effects: Lessons from the consumer response to the 2007 toy recalls. Rev. Econom. Statist. 94(2):499–516.Crossref, Google Scholar
• Hartman R (1987) Product quality and market efficiency: The effect of product recalls on resale prices and firm valuation. Rev. Econom. Statist. 69(2):367–372.Crossref, Google Scholar
• Hauser J, Shugan S (1983) Defensive marketing strategies. Marketing Sci. 2(4):319–360.Link, Google Scholar
• Kalaignanam K, Kushwaha T, Eilert M (2013) The impact of product recalls on future product reliability and future accidents: Evidence from the automobile industry. J. Marketing 77(2):41–57.Crossref, Google Scholar
• Kamenica E (2008) Contextual inference in markets: On the informational content of product lines. Amer. Econom. Rev. 98(5):2127–2149.Crossref, Google Scholar
• Kuksov D, Villas-Boas JM (2010) When more alternatives lead to less choice. Marketing Sci. 29(3):507–524.Link, Google Scholar
• Marsh T, Schroeder T, Mintert J (2004) Impacts of meat product recalls on consumer demand in the USA. Appl. Econom. 36(9):897–909.Crossref, Google Scholar
• Rao R, Turner R (1984) Organization and effectiveness of the multiple product salesforce. J. Personal Selling Sales Management 4(1):24–30.Google Scholar
• Roehm M, Tybout A (2006) When will a brand scandal spill over, and how should competitors respond? J. Marketing Res. 53(4):366–373.Crossref, Google Scholar
• Rockoff JD (2013) Lilly plans to lay off 30% of its sales reps. Wall Street Journal (April 11), https://www.wsj.com/news/articles/SB10001424127887324240804578417111074635032.Google Scholar
• Shankar V (1997) Pioneers’ marketing mix reactions to entry in different competitive game structures: Theoretical analysis and empirical illustration. Marketing Sci. 16(3):271–293.Link, Google Scholar
• Shankar V (1999) New product introduction and incumbent response strategies: Their interrelationship and the role of multimarket contact. J. Marketing Res. 36(4):327–344.Crossref, Google Scholar
• Thirumalai S, Sinha K (2011) Product recalls in the medical device industry: An empirical exploration of the sources and financial consequences. Management Sci. 57(2):376–392.Link, Google Scholar
• Wysowski D, Swartz L (2005) Adverse drug event surveillance and drug withdrawals in the United States 1969–2002. Arch. Internal Medicine 165(12):1363–1369.Crossref, Google Scholar